C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
530/15.14, 530/7
C07K 14/59 (2006.01) A61K 38/24 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1341284
Described are new glycoprotein hormones capable of competing with natural hormones for the normal receptor binding sites but substantially incapable of effecting post receptor activities. The glycoprotein hormones of the present invention have had specific (rather than all) oligosaccharide chains removed so as to effectively diminish biologic activity while not significantly reducing plasma half-life, thus improving the molecules effectiveness as an antagonist compared with conventionally produced molecules. The preferred glycoprotein hormones are ideally obtained by site-directed mutagenesis to selectively deglycosylate the protein. Also described are therapeutic treatments comprising the administration of the recombinant glycoprotein hormones of the present invention as hormone antagonists.
585309
Bernstine Edward G.
Chappel Scott C.
Gowling Lafleur Henderson Llp
Integrated Genetics Inc.
Merck Serono Sa
LandOfFree
Site-directed mutagenesis modified glycoprotein hormones and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Site-directed mutagenesis modified glycoprotein hormones and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Site-directed mutagenesis modified glycoprotein hormones and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1228586